New clinical results offer hope to 95 million pain sufferers

In a paper presented to the executive committee of the American College of Sports Medicine, Bassil Aish, M.D., reported that 90 percent of the patients who participated in a study of the Magnetic Resonance Analyzer (MRA) reported a greater than 70 percent improvement in their acute and chronic pain. The study population in this latest paper represents more than 700 treatments of a variety of hard and soft tissue ailments ranging from sports injuries to arthritis.

The Magnetic Resonance Analyzer (MRA) is a non-invasive pain analysis and treatment device that has been tested successfully on Olympic and professional athletes.

The MRA locates and treats pain by analyzing and correcting the abnormal magnetic resonance patterns exhibited by injured or diseased tissue. The MRA corrects abnormal resonance patterns by applying a neutralizing resonance pattern to the tissue at the site of pain.

The MRA is currently being evaluated for use in the alleviation of acute sports injuries such as strains, sprains, joint injuries and musculoskeletal injuries as well as for severe and chronic pain conditions like arthritis, migraine headaches and fibromyalgia.

Like an MRI, the MRA operates at the atomic and molecular level. The MRA measures reactions generated through atomic and molecular particle movement. This movement is known to produce a specific energy known as magnetic resonance.

Magnetic resonance patterns emitted by each of the body’s tissues and physiological structures have unique characteristics. According to the inventor of the MRA, pain occurring from injured or diseased tissue is the result of disorder in the magnetic resonance pattern and movement of atoms and molecules.

By administering a counter or correcting magnetic resonance pattern through the MRA, the magnetic resonance pattern of the particles and their movement become realigned, normalizing cellular function and as a result, may reduce and/or alleviate pain.

The MRA technology offers new hope for the 95 million Americans who suffer from chronic and acute pain. The MRA technology is available on a limited basis through clinical trials underway at Applied Magnetic Resonance, LLC, 4505 Las Virgenes Road, Ste. 204, Calabasas. Reach them at (818) 878-6840.